ARL4C and cancer: We also explored the effect of ARL4C expression on various clinical features of KIRC, and we found that ARL4C was not only differentially expressed in normal tissues versus primary tumors but also correlated with the cancer stage of patients, lymph node metastasis status, sex, age, tumor grade, KIRC subtype, and race (Figures 3(c)–3(j)).